Efficacy and safety of a 7.5% Icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis

American Journal of Kidney Diseases

Volumn 39, Issue 4, 2002, Pages 862-871

  Plum, Joerg ^a   Gentile, Stella ^a   Verger, Christian ^a   Brunkhorst, Reinhart ^a   Bahner, Udo ^a   Faller, Bernadette ^a   Peeters, Jacky ^a   Freida, Philippe ^a   Struijk, Dick G ^a   Krediet, Raymond T ^a   Grabensee, Bernd ^a   Tranaeus, Anders ^a   Filho, José C Divino ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Automated peritoneal dialysis; Icodextrin; Metabolic effects; Sodium; Ultrafiltration

Indexed keywords

DIANEAL; EXTRANEAL; ICODEXTRIN;

ADULT; ARTICLE; CARBOHYDRATE ABSORPTION; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFICACY; DRUG SAFETY; ENZYME ACTIVITY; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; MALE; PERITONEAL DIALYSIS; RANDOMIZED CONTROLLED TRIAL; SODIUM BALANCE; ULTRAFILTRATION; URINE VOLUME;

EID: 0036200173     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/ajkd.2002.32009     Document Type: Article

References (25)

1. Continuous ambulatory peritoneal dialysis: Eight years of experience at a single center
2. Permanent loss of ultrafiltration capacity of the peritoneum in long-term peritoneal dialysis: An epidemiological study
3. Peritoneal fluid transport in CAPD patients with permanent loss of ultrafiltration capacity
4. Ultrafiltration failure and dialysate glucose in CAPD
5. Strategies to improve clinical outcomes in peritoneal dialysis patients: Delivered dose and membrane transport
6. What really happens to people on long-term peritoneal dialysis?
7. Icodextrin 7.5% dialysate solution (glucose polymer) in patients with ultrafiltration failure: Extension of CAPD technique survival
8. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD
9. Icodextrin instead of glucose during the daytime dwell in CCPD increases ultrafiltration and 24-h dialysate creatinine clearance
10. Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis
11. Interference of icodextrin dialysate with serum amylase activity measurement in peritoneal dialysis patients
12. Peritoneal membrane transport function in children receiving long-term dialysis
13. Direct determination of polyglucose metabolites in plasma using anionexchange chromatography with pulsed amperometric detection
14. NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy
15. Peritoneal transport characteristics with glucose polymer based dialysate
16. Peritoneal fluid and solute transport with different polyglucose formulations
17. Serum disaccharides and osmolality in CCPD patients using icodextrin or glucose as daytime dwell
18. Single daily overnight (12-h dwell) use of 7.5% glucose polymer (Mw 18700; Mn 7300) +0.35% glucose solution: A 3-month study
19. Icodextrin 7.5% dialysate for diurnal exchange in patients treated with CCPD
20. Alterations of exocrine pancreas in end-stage renal disease: Do they reflect a clinically relevant uremic pancreopathy?
21. Allergic reactions to icodextrin in patients with renal failure
22. Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis
23. Effect of dwell time on carbonyl stress using icodextrin and amino acid peritoneal dialysis fluids
24. Cell function and viability in glucose polymer peritoneal dialysis fluids
25. The effect of alternative peritoneal dialysis solutions on cell viability, apoptosis/necrosis and cytokine expression in human monocytes